(-)-DHMEQ structure
|
Common Name | (-)-DHMEQ | ||
|---|---|---|---|---|
| CAS Number | 287194-40-5 | Molecular Weight | 261.23000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C13H11NO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (-)-DHMEQ(–)-DHMEQ is a potent NF-κB inhibitor. |
| Name | 2-hydroxy-N-[(1S,2S,6S)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzamide |
|---|---|
| Synonym | More Synonyms |
| Description | (–)-DHMEQ is a potent NF-κB inhibitor. |
|---|---|
| Related Catalog | |
| Target |
RelA RelB |
| In Vitro | (–)-DHMEQ binds to cysteine 38 of RelA and cysteine 144 of RelB. (−)-DHMEQ at concentrations greater than 25 µM inhibits the LTβ-induced nuclear translocation of FLAG-RelB WT, whereas the inhibitory effect of (–)-DHMEQ on the nuclear translocation of FLAG-RelB (C144S) became weaker at the same concentrations[1]. |
| Cell Assay | A549 cells transfectants stably expressing RelB WT and RelB (C144S) are preincubated with various concentrations of (-)-DHMEQ (1, 5, 10, 25, and 50 μM) for 1h and then incubated with or without LTβ (25 ng/mL) for 2 h in the presence or absence of (-)-DHMEQ.Cytoplasmic and nuclear extracts are analyzed by Western blotting[1]. |
| References |
| Molecular Formula | C13H11NO5 |
|---|---|
| Molecular Weight | 261.23000 |
| Exact Mass | 261.06400 |
| PSA | 102.65000 |
| LogP | 0.29170 |
| (-)-DHM2EQ |
| DHMEQ |
| Dehydroxymethylepoxyquinomicin |
| 2-Hydroxy-N-((1S,2S,6S)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)benzamide |
| (-)-DHMEQ |